Angiogenesis Inducing Agents
- Name
- Angiogenesis Inducing Agents
- Accession Number
- DBCAT000215
- Description
Agents that induce or stimulate PHYSIOLOGIC ANGIOGENESIS or PATHOLOGIC ANGIOGENESIS.
- Drugs
Drug Drug Description Becaplermin A recombinant form of human platelet-derived growth factor used to treat ulcers due to diabetic neuropathy in the lower extremities when there is adequate blood supply to the area. - Drugs & Drug Targets
Drug Target Type Becaplermin Platelet-derived growth factor receptor beta target Becaplermin Alpha-2-macroglobulin target Becaplermin Platelet-derived growth factor receptor alpha target